As an experimental drug, BPC-157 for sale is only available for research and educational purposes
Research suggests high intravenous doses can improve liver function in patients with fatty liver disease
This gives you 5mg/ml (same concentration as the 5mg/1ml example), keeping your dose math consistent
10.3389/fphar.2021.632295 Summary Keywords gastric pentadecapeptide BPC 157, primary abdominal compartment syndrome, rats, brain edema, lung edema Citation Tepes M, Gojkovic S, Krezic I, Zizek H, Vranes H, Madzar Z, Santak G, Batelja L, Milavic M, Sikiric S, Kocman I, Simonji K, Samara M, Knezevic M, Barisic I, Lovric E, Strbe S, Kokot A, Sjekavica I, Kolak T, Skrtic A, Seiwerth S, Boban Blagaic A and Sikiric P (2021) Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in Rats
Molecular Profile & Structural Composition Molecular Formula: C62H98N16O22 Molecular Weight: 1419.53 g/mol Sequence: 15 amino acids (pentadecapeptide) Purity: 99% (HPLC verified) Form: Lyophilized powder Key Research Areas: What Studies Explore About BPC-157 Preclinical research on BPC-157 has spanned a wide range of biological systems and mechanisms